Investment Column : Alliance Pharma | 09-Sep-2010 | The Independent |
Investment Column:Alliance Pharma | 19-Mar-2009 | The Independent |
Market report: Thursday latest | 13-Sep-2007 | Daily Mail |
Gloomy summer casts shadow over Next | 10-Sep-2007 | The Independent |
Currency | UK Pounds |
Share Price | 33.10p |
Change Today | -0.60p |
% Change | -1.78 % |
52 Week High | 71.80 |
52 Week Low | 32.90 |
Volume | 1,864,058 |
Shares Issued | 540.40m |
Market Cap | £178.87m |
RiskGrade | 119 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 4 |
Buy | 0 |
Neutral | 3 |
Sell | 0 |
Strong Sell | 0 |
Total | 7 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 22-Jun-23 | 22-Dec-22 |
Paid | 18-Jul-23 | 19-Jan-23 |
Amount | 1.18p | 0.59p |
Time | Volume / Share Price |
16:35 | 83,605 @ 33.10p |
16:35 | 4,891 @ 33.10p |
16:35 | 1,099 @ 33.10p |
16:35 | 1,203 @ 33.10p |
16:35 | 1,817 @ 33.10p |
CEO | Peter Butterfield |
CFO | Andrew Franklin |
Chair | Camillo Pane |
You are here: research